Paola Torre

Headache and Alzheimer's disease.

Reading errors in patients with cerebellar vermis lesions.

Ten-Point Clock Test: a correlation analysis with other neuropsychological tests in dementia.

Effects of selegiline on fronto-temporal dementia: a neuropsychological evaluation.

Peculiar aspects of reading and writing performances in patients with olivopontocerebellar atrophy.

Gabapentin treatment of glossopharyngeal neuralgia: a follow-up of four years of a single case.

Complex cognitive disruption in motor neuron disease.

Complex distal movement in cortical-basal ganglionic degeneration. A functional evaluation.

Rivastigmine in subcortical vascular dementia: an open 22-month study.

Use of galantamine to treat vascular dementia.

Cognitive changes following subthalamic nucleus stimulation in two patients with Parkinson disease.

Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study.

Depression and Alzheimer's disease: symptom or comorbidity?

Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients.

Rivastigmine in subcortical vascular dementia: a randomized, controlled, open 12-month study in 208 patients.

Writing errors by normal subjects.

Neuropsychological changes after subthalamic nucleus stimulation: a 12 month follow-up in nine patients with Parkinson's disease.

Gabapentin for the treatment of behavioural alterations in dementia: preliminary 15-month investigation.

Gabapentin as a drug therapy of intractable hiccup because of vascular lesion: a three-year follow up.

Olanzapine as a possible treatment for anxiety due to vascular dementia: an open study.

Rivastigmine in vascular dementia.

Vitamin B12 and folate depletion in cognition: a review.

[Freezing of gait is a symptom of Parkinson disease].

Vitamin B12 and folate depletion: clinical evidence in a neurological population.

Rivastigmine in frontotemporal dementia: an open-label study.

Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.

Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia.

Use of the ten-point clock test to compare executive functioning across 24 months in patients with subcortical vascular dementia.

Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: risks of cerebrovascular events. A controlled, open-label study.

Frontal lobe dementia and subcortical vascular dementia: a neuropsychological comparison.

Cognitive impairment in the lateralized phenotype of corticobasal degeneration.

[Role of the cerebellum in the control of distal motor activities in patients with akinetic-rigid Parkinson disease].

Behavioral alterations and vascular dementia.

Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer's disease: risks or benefits.

In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos.

Peripheral neuropathy in hepatitis C virus-related mixed cryoglobulinaemia: existing treatments and a positive symptomatic response to oxcarbazepine.

Rivastigmine and Parkinson dementia complex.

Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia.

Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX).

Risk factors for vascular dementia: hypotension as a key point.

Gait and equilibrium in subcortical vascular dementia.

The on-freezing phenomenon: cognitive and behavioral aspects.

Depression in vascular pathologies: the neurologist's point of view.

Apathy: a complex symptom specific to the clinical pattern of presentation of Parkinson's disease?